Kevin Stanley, MD
Orthopaedic Surgery · Mooresville, NCNPI 1144238338
Payments from drug & device makers
Across 55 payments — averaging $76.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$2K
- Smith+Nephew$1K
- Orthofix Medical, Inc.$286
- Peerless Surgical Inc.$180
- Catalyst Orthoscience$153
- Johnson & Johnson$149
- plus $360 from 9 others
What the payments were for
- Travel & lodging$1,94647%
- Food & beverage$2,23753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 14 | $1,715 |
| Smith+Nephew | 6 | $1,340 |
| Orthofix Medical, Inc. | 14 | $286 |
| Peerless Surgical Inc. | 3 | $180 |
| Catalyst Orthoscience | 2 | $153 |
| Johnson & Johnson | 3 | $149 |
| Globus Medical | 2 | $122 |
| Stryker | 2 | $68 |
| Organogenesis Inc. | 2 | $48 |
| Bioventus LLC | 2 | $35 |
| Dynasplint Systems Inc. | 1 | $27 |
| Amgen | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Shoulder Innovations, Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMISTEM$1,123
- Journey II BCS$925
- Legion Revision$925
- Legion Hinge$925
- Orthosensor$724
- Anthology$724
- REDAPT Revision Hip System$201
- NOVOSTITCH$147
- Bone Anchors with Arthroscopic Delivery System$145
- Archer CSR Total Shoulder System$107
- Archer R1 Reverse Shoulder System$107
How this compares
$4,182 in reported general payments places this provider in the 45th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 388 | $4,773 |
| Meloxicam | 665 | $2,394 |
| Methylprednisolone | 146 | $1,006 |
| Diclofenac Sodium | 56 | $749 |
| Oxycodone Hcl | 127 | $533 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $220 |
| Cephalexin | 67 | $136 |
| Ibuprofen | 17 | $102 |
| Mupirocin | 11 | $90 |
| Hydromorphone Hcl | 26 | $77 |
| Tramadol Hcl | 35 | $69 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mooresville
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$6.2M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Mark EasleyDurham$4.2M
- Carroll JonesCharlotte$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.